Levodopa, carbidopa, and pyridoxine in Parkinson disease. Metabolic interactions.
D002230:Carbidopa / Q000378:metabolism / Q000627:therapeutic use; D004295:Dihydroxyphenylalanine / Q000097:blood / Q000378:metabolism* / Q000627:therapeutic use / Q000652:urine; D004296:Dopa Decarboxylase / Q000097:blood / Q000652:urine; D004298:Dopamine / Q000097:blood; D004347:Drug Interactions; D004357:Drug Synergism; D006719:Homovanillic Acid / Q000097:blood / Q000652:urine; D006801:Humans; D006834:Hydrazines / Q000378:metabolism*; D010300:Parkinson Disease / Q000097:blood / Q000188:drug therapy / Q000378:metabolism* / Q000652:urine; D011736:Pyridoxine / Q000378:metabolism* / Q000627:therapeutic use
D006834:Hydrazines; D004295:Dihydroxyphenylalanine; D004296:Dopa Decarboxylase; D011736:Pyridoxine; D002230:Carbidopa; D004298:Dopamine; D006719:Homovanillic Acid